These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26987122)

  • 1. Charge Variants of an Avastin Biosimilar Isolation, Characterization, In Vitro Properties and Pharmacokinetics in Rat.
    Zhao YY; Wang N; Liu WH; Tao WJ; Liu LL; Shen ZD
    PLoS One; 2016; 11(3):e0151874. PubMed ID: 26987122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarity demonstrated between isolated charge variants of MB02, a biosimilar of bevacizumab, and Avastin® following extended physicochemical and functional characterization.
    Ruppen I; Beydon ME; Solís C; Sacristán D; Vandenheede I; Ortiz A; Sandra K; Adhikary L
    Biologicals; 2021 Sep; 73():41-56. PubMed ID: 34593306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similarity demonstrated between isolated charge variants of MB02, a biosimilar of bevacizumab, and Avastin® following extended physicochemical and functional characterization.
    Ruppen I; Beydon ME; Solís C; Sacristán D; Vandenheede I; Ortiz A; Sandra K; Adhikary L
    Biologicals; 2022 Jun; 77():1-15. PubMed ID: 35667958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical and Biological Characterization of RTXM83, a New Rituximab Biosimilar.
    Cerutti ML; Pesce A; Bès C; Seigelchifer M
    BioDrugs; 2019 Jun; 33(3):307-319. PubMed ID: 30927214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charge variants of proposed biosimilar to Omalizumab: Isolation, purification and analysis by HPLC methods.
    Gupta T; Seshadri S
    Ann Pharm Fr; 2024 Jan; 82(1):64-71. PubMed ID: 37708991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Physicochemical and Biological Characterization of the Proposed Biosimilar Darbepoetin Alfa, LBDE, and Its Originator Darbepoetin Alfa, NESP
    Jeong YR; Jeong RU; Son JH; Kwon JC; Jung S; Song MA; Hwang JA; Lee GM
    BioDrugs; 2018 Apr; 32(2):153-168. PubMed ID: 29556960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and Functional Analysis of CEX Fractions Collected from a Novel Avastin
    Gurel B; Berksoz M; Capkin E; Parlar A; Pala MC; Ozkan A; Capan Y; Daglikoca DE; Yuce M
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC-MS based case-by-case analysis of the impact of acidic and basic charge variants of bevacizumab on stability and biological activity.
    Singh SK; Kumar D; Malani H; Rathore AS
    Sci Rep; 2021 Jan; 11(1):2487. PubMed ID: 33514790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of monoclonal antibodies for measuring Avastin and its biosimilar by Sandwich ELISA.
    Li M; An W; Wang L; Zhang F; Li J; Zhang Y; Li Y; Li H; Ren W; Zhao R; Xia C; Sun L
    J Immunol Methods; 2019 Jun; 469():42-46. PubMed ID: 30943379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonclinical assessments of the potential biosimilar PF-06439535 and bevacizumab.
    Peraza MA; Rule KE; Shiue MHI; Finch GL; Thibault S; Brown PR; Clarke DW; Leach MW
    Regul Toxicol Pharmacol; 2018 Jun; 95():236-243. PubMed ID: 29574193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic Comparability of a Biosimilar Trastuzumab Anticipated from Its Physicochemical and Biological Characterization.
    Miranda-Hernández MP; López-Morales CA; Piña-Lara N; Perdomo-Abúndez FC; Pérez NO; Revilla-Beltri J; Molina-Pérez A; Estrada-Marín L; Flores-Ortiz LF; Ruiz-Argüelles A; Medina-Rivero E
    Biomed Res Int; 2015; 2015():874916. PubMed ID: 26682224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetic modeling of PF-06439535 (a bevacizumab biosimilar) and reference bevacizumab (Avastin
    Li CSW; Sweeney K; Cronenberger C
    Cancer Chemother Pharmacol; 2020 Mar; 85(3):487-499. PubMed ID: 31768697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trastuzumab Charge Variants: a Study on Physicochemical and Pharmacokinetic Properties.
    Torkashvand F; Mehranfar M; Rashidi Gero M; Jafarian P; Mirabzadeh E; Azarian B; Sardari S; Vaziri B
    Iran Biomed J; 2023 Mar; 27(2 & 3):108-16. PubMed ID: 37070702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of isoelectric points and relative charge variants of 23 therapeutic monoclonal antibodies.
    Goyon A; Excoffier M; Janin-Bussat MC; Bobaly B; Fekete S; Guillarme D; Beck A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Oct; 1065-1066():119-128. PubMed ID: 28961486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetics of MYL-1402O, a Proposed Biosimilar to Bevacizumab and Reference Product (Avastin
    Owen JS; Rackley RJ; Hummel MA; Roepcke S; Huang H; Liu M; Idris TA; Murugesan SMN; Marwah A; Loganathan S; Ranganna G; Barve A; Waller CF; Socinski MA
    Eur J Drug Metab Pharmacokinet; 2023 Nov; 48(6):675-689. PubMed ID: 37792130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Control Laboratory Assessment of Quality of Rituximab Biosimilars in India.
    Mishra NN; Sharma A; Shalini S; Sharma S; Jain P; Sharma RK; Chander H; Prasad JP; Anvikar AR; Chand S
    Monoclon Antib Immunodiagn Immunother; 2022 Oct; 41(5):260-274. PubMed ID: 36306517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, single-blind, Phase I trial (INVICTAN-1) assessing the bioequivalence and safety of BI 695502, a bevacizumab biosimilar candidate, in healthy subjects.
    Hettema W; Wynne C; Lang B; Altendorfer M; Czeloth N; Lohmann R; Athalye S; Schliephake D
    Expert Opin Investig Drugs; 2017 Aug; 26(8):889-896. PubMed ID: 28651442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative charge-based separation study with various capillary electrophoresis (CE) modes and cation exchange chromatography (CEX) for the analysis of monoclonal antibodies.
    Kahle J; Zagst H; Wiesner R; Wätzig H
    J Pharm Biomed Anal; 2019 Sep; 174():460-470. PubMed ID: 31228849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionation and online mass spectrometry based on imaged capillary isoelectric focusing (icIEF) for characterizing charge heterogeneity of therapeutic antibody.
    Kwok T; Zhou M; Schaefer A; Bo T; Li V; Huang T; Chen T
    Anal Methods; 2023 Jan; 15(4):411-418. PubMed ID: 36537584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SpeB proteolysis with imaged capillary isoelectric focusing for the characterization of domain-specific charge heterogeneities of reference and biosimilar Rituximab.
    Zhang Z; Perrault R; Zhao Y; Ding J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1020():148-57. PubMed ID: 27038651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.